[1] Anton Y. Peleg, M.B., B.S.,et al.Hospital-Acquired Infections Due to Gram-Negative Bacteria[J]. N Engl J Med,2010,362:1804-1813. [2] GG.Christian, LM.Dominique, C.Otto, et al. Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli[J]. Antimicrobial agents and chemotherapy,2008,52(3):813. [3] Tao Hong, Ellen Smith Moland, Baha Abdalhamid,et al. Escherichia coli: Development of Carbapenem Resistance During Therapy[J].Clinical Infectious Diseases.2005,40:e84-86. [4] Cesar A. Arias,Barbara E,Murray. Antibiotic-Resistant Bugs in the 21st Century -A Clinical Super-Challenge[J].N Engl J Med,2009,360:439-443. [5] 丁凡,王忠振.滑动平均法的改良及其在大肠埃希菌头孢他啶耐药性拟合中的应用[J]. 中国医院用药评价与分析,2010,10(4):320-321. [6] 丁凡,黄晓明,王和.线性拟合法应用于大肠埃希菌头孢他啶耐药性趋势分析的初步研究[J].贵州医药,2009,33(10):867. [7] Ding, F., D. Zarlenga, Ren X,et al. A novel algorithm to define infection tendencies in H1N1 cases in mainland China[J]. Infection, Genetics and Evolution,2011,11:222-226. [8] 熊和金,徐华中.灰色控制[M].北京:国防工业出版社,2005:6-87. [9] 潘红宇.时间序列分析[M].北京:对外经济贸易大学出版社,2006:7-42. [10] 赵颖,徐英春,张小江.Mohnarin2006-2007年度报告:肠杆菌科细菌耐药监测结果[J].中国抗生素杂志,2008.33(10):602-607. [11] 窦红涛,谢秀丽,张小江,等.Mohnarin 2008年度报告:肠杆菌科细菌耐药监测[J].中国抗生素杂志,2010,35(7):556-560. [12] 肖永红,王进,赵彩云,等.2006-2007年Mohnarin细菌耐药监测[J].中华医院感染学杂志,2008,18(8):1051. [13] 肖永红,王进,朱燕,等. Mohnarin 2008年度全国细菌耐药监测[J].中华医院感染学杂志,2010,20(16):2377-2383. [14] Angela Novais,Rafael Canton,Teresa M. Coque,et al.Mutational Events in Cefotaximase Extended-Spectrum-Lactamases of the CTX-M-1 Cluster Involved in Ceftazidime Resistance[J]. Antim- icrobial Agents And Chemotherapy.2008,52(7):2377-2382. [15] Marina N. Stepanova, Maxim Pimkin, Anatoly A. Nikulin,et al.Convergent In Vivo and In Vitro Selection of Ceftazidime Resistance Mutations at Position 167 of CTX-M-3-Lactamase in Hypermutable Escherichia coli Strains[J]. Antimicrobial Agents And Chemotherapy.2008,52(4): 1297-1301. [16] Drug-resistance control policy and measures in Clinic and Drug abuse in hospital[EB/OL]. http://www.moh.gov.cn/publicfiles//bu-siness/ htmlfiles/mohywzc/index.htm. [17] Conan MacDougall,Ron E. Polk.Antimicrobial Stewardship Programs in Health Care Systems[J].Clinical Microbiology Reviews. 2005,18(4):638-656. [18] Wan fu ,Zhu De Mei.The use of antibiotics and drug resistance in a hospital:a periodic report on years 2001 to 2005[J].Chinese Remedies and Clinics.2007,7(2):98-102. [19] Atle Fretheim, Morten Aaserud, Andrew D. Oxman. Rational Prescribing in Primary Care(RaPP):Economic Evaluation of an Intervention to Improve Professional Practice[J]. PLoS Medicine.2006,3(6):792-799. [20] C.Pen a, C.Suarez, F.Tubau,et al. Nosocomial Outbreak of a Non-Cefepime-Susceptible Ceftazidime-Susceptible Pseudomonas aeruginosa Strain Overexpressing MexXY-OprM and Producing an Integron-Borne PSE-1β-Lactamase[J].Journal of Clinical Microbiology, 2009,47(8):2381-2387. |